Share: Facebook Twitter LinkedIn
Activity Provided By:


Apixaban Steps Up to the Plate: The Use of Apixaban for Treatment of Venous Thromboemboli in Patients with Cancer

Access Activity

Overview / Abstract:

The incidence of venous thromboemboli (VTE) development in patients with cancer has been reported as much as four to seven-fold higher than that for non-cancer patients. Anticoagulation management remains challenging for these patients, due to the higher risk of recurrent VTE (despite anticoagulant therapy) and bleeding complications, compared to patients without cancer. This application-based continuing pharmacy education activity will provide a 'journal club format' discussion for pharmacists and student pharmacists to analyze the long-awaited results of the Caravaggio Trial. Join us for a dynamic discussion reviewing the outcomes and implications of this trial, in light of the current data supporting the use of warfarin, low molecular weight heparins, and direct oral anticoagulants for the treatment of venous thromboemboli in patients with cancer.


Jul 08, 2023


Pharmacy CPE


Online, Webinar / Webcast / Video



Credits / Hours




Presenters / Authors / Faculty

Loriel Solodokin, PharmD
Assistant Professor of Pharmacy Practice
Clinical Oncology Pharmacist
MCPHS University

Keywords / Search Terms

CEI Impact CEI Impact CEI ce, journal club, trial, vte, clinical trial, journal, apixaban, venous thromboemboli, caravaggio trial, doac, cancer

Access Activity

CORE Higher Education Group,, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the website or within our mobile apps.CORE Higher Education Group,, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the Terms of Service. Site Map